Although subsequent meta‐analyses found no significant mortality increase with anti‐VEGF compared to laser in ROP (Sankar et al., 2018; Taher et al., 2022), Natarajan et al. (2019) still reported higher mortality rates associated with anti‐VEGF use. Here, VEGFA is linked to retinopathy of prematurity.